Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn

Irish Medical Journal

Volumn 101, Issue 2, 2008, Pages

  Walsh, S A ^a   Yao, N ^a   El Khuffash, A ^a   Twomey, A ^a   Molloy, Elesean J ^a  

^a NATIONAL MATERNITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN; IMMUNOGLOBULIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EXCHANGE BLOOD TRANSFUSION; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MALE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN INTENSIVE CARE; PHOTOTHERAPY; REPEATED DRUG DOSE; TREATMENT OUTCOME; BLOOD; GESTATIONAL AGE; INTRAVENOUS DRUG ADMINISTRATION; RETROSPECTIVE STUDY;

BILIRUBIN; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45549105352     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Imbach P, d'Apuzzo V, Hirt A et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1: 1228-31.
2. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997;350:620-3.
3. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by highdose intravenous gamma globulin. N Engl J Med 1982;306:1254-18.
4. Wenkse G, Gaedicke G, Heyes H. Idiopathic thrombocytopaenic purpura in pregnancy and neonatal period. Blut 1984;48:377-82.
5. Bussel JB, Berkowitz RL, Lynch L et al. Antenatal management of alloimmune thrombocytopenia with intravenous imunoglobulin: a randomized trial of the addition of low-dose steroid to intravenous imunoglobulin. Am J Obstet Gynecol 1996;174:1414-23.
6. Voto LS, Mathet ER, Zapaterio JL et al. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997;25:85-8.
7. Doreen MC, van-Kamp IL, Scherpenisse JW et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox-Sang 1994;66:253-7.
8. Alonso JG, Decaro J, Marrero A et al. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease. J Perinat Med 1994;22:415-19.
9. Ouwehand WH, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000;82:F173-5.
10. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. (Cochrane Review). The Cochrane Library Oxford: Update Software, 2000:Issue 3.
11. Stanley TV, Grimwood K. Classical Kawasaki disease in a neonate. Arch Dis Child Fetal Neonatal Ed 2002;86:F135-6.
12. Urbaniak SJ. ADCC (K cell) lysis of human erythrocytes sensitized with Rhesus alloantibodies. II. Investigation into mechanism of lysis. Br J Haematol 1979;42:315-28.
13. Gottstein R, Cooke RWI. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003;88:F6-F10.
14. Subcommittee on Hyperbilirubinemia. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 2004;114:297-316.
15. Rubo J, Wahn V. High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility. Infusions Ther Transfusion Med 1993;20:104-8.